Prolonged sevoflurane inhalation was not nephrotoxic in two patients with refractory status asthmaticus

Anesthesia and Analgesia

Volumn 83, Issue 1, 1996, Pages 189-191

  Mori, Naohisa ^a   Nagata, Hirofumi ^a   Ohta, Sukejuro ^a   Suzuki, Masahiro ^a  

^a AKITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; DEXAMETHASONE; FLUORIDE ION; NITROUS OXIDE; OXYGEN; SEVOFLURANE; STEROID; THEOPHYLLINE;

ADULT; AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; ASTHMATIC STATE; CASE REPORT; GENERAL ANESTHESIA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL;

ADULT; ANESTHETICS, INHALATION; ETHERS; FLUORIDES; HUMANS; KIDNEY; MALE; METHYL ETHERS; MIDDLE AGED; STATUS ASTHMATICUS; TIME FACTORS;

EID: 0029931629     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199607000-00035     Document Type: Article

References (17)

1. Robertson CE, Steedman D, Sinclair CJ, et al. Use of ether in life-threatening acute severe asthma. Lancet 1985;1:187-8.
2. Bayliff CD, Koch JP, Faclier G. The use of halothane in the treatment of status asthmaticus. Drug Intell Clin Pharm 1985;19:307-9.
3. Schwartz SH. Treatment of status asthmaticus with halothane. JAMA 1984;251:2688-9.
4. Bierman MI, Brown M, Muren O, et al. Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med 1986;14:832-3.
5. Revell S, Greenhalgh D, Absalom SR, Soni N. Isoflurane in the treatment of asthma. Anaesthesia 1988;43:477-9.
6. Saitoh K, Fukuda H, Hirabayashi Y, Shimizu R. Sevoflurane anesthesia for asthmatic patients: report of five cases. Jpn J Anesth 1992;41:1998-2001.
7. Pasch T, Kamp HD, Petermann H. The effect of halothane, enflurane and isoflurane on resistance and compliance in patients with asthma or chronic obstructive lung diseases. Anaesthetist 1991;40:65-71.
8. Mercier FJ, Benhamou D, Denjean A. Lack of bronchodilator effect after administration of subanaesthetic concentration of isoflurane in mild asthmatic subjects challenged with methacholine. Br J Anaesth 1995;74:301-5.
9. Frink EJ Jr, Ghantous H, Malan TP, et al. Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function. Anesth Analg 1992;74:231-5.
10. Holiday DA, Smith FR. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 1981;54:100-6.
11. Cousins MJ, Mazze RI. Methoxyflurane nephrotoxicity: a study of dose-response in man. JAMA 1973;225:1611-6.
12. Mazze RI, Calverly RK, Smith NT. Inorganic fluoride nephrotoxicity: prolonged enflurane and halothane anesthesia in volunteers. Anesthesiology 1977;46:265-71.
13. Kazama T, Ikeda K. The effect of prolonged administration of sevoflurane on serum concentration of fluoride ion in patients [abstract]. Anesthesiology 1991;75:A346.
14. Higuchi H, Arimura S, Sumikura H, et al. Urine concentrating ability after prolonged sevoflurane anaesthesia. Br J Anaesth 1994;73:239-40.
15. Kobayashi Y, Ochiai R, Takeda J, et al. Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans. Anesth Analg 1992;74:753-7.
16. Kharasch ED, Hankins DC, Thummel KE. Human kidney methoxyflurane and sevoflurane metabolism: intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology 1995;82:689-99.
17. Malan TP, Kadota Y, Mata H, et al. Renal function after sevoflurane or enflurane anesthesia in the Fischer 344 rat. Anesth Analg 1993;77:817-21.